AMS
American Shared Hospital Services
Healthcare · Medical Care Facilities · ASE

$1.61
Close 2026-05-14
✗ ETHICAL FAIL

WEAK MOAT

HIGH
Data Confidence: 100%
Full financial profile available

Market Cap
$10.7M
Trailing P/E
Forward P/E
4.03
Rev Growth
-14.8%
Profit Margin
-5.5%
ROE
-9.4%
Analyst Target
$4.00
Recommendation
NONE

About American Shared Hospital Services

American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Opportunity Summary
Trading at $2 against a fair value of $6, a 73% discount. Fails ethical screen (Debt ratio). Ranks better than 68% of screened stocks.

Ethical Screen
Business Activity PASS
Debt Ratio (2.03%) FAIL
Cash Ratio (0.32%) PASS
Receivables Ratio (0.00%) PASS
Revenue Ratio (0.00%) PASS
Overall FAIL
Score Ethical: 10.0
Score Valuation: 95.0
Score Quality: 15.0
Score Combined: 40.0
Fair Value Est: $6.00 · Margin of Safety: +272.7% · Tier: AVOID

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership

Opportunity Scores
Valuation85.0
Quality0.0
Cash Flow50.0
Moat25.0
Balance Sheet74.7
Debt Purity0.0
Liquid Purity1.7
Rev Purity100.0
Compliance29.9
Tier: SILVER · Score: 61.8 · Rank: #447

Earnings History (Last 8 Quarters)
Date EPS Est. Reported EPS Surprise %
2026-08-13 -0.02 Pending
2026-05-14 -0.01 -0.09 -800.0%
2026-03-31 0.02 -0.09 -550.0%
2025-11-13 Pending
2025-08-13 -0.07 -0.04 +42.9%
2025-05-15 0.04 -0.10 -350.0%
2025-04-04 0.01 -0.22 -2317.3%
2024-11-13 0.08 -0.03 -137.5%

Quarterly Financials
Period Revenue Net Income EBITDA Gross Profit Op. Income EPS
2026-03-31 $7.1M -$612.0K $726.0K $1.3M -$622.0K -0.09
2025-12-31 $7.7M -$631.0K $419.0K $906.0K -$1.1M -0.09
2025-09-30 $7.2M -$17.0K $1.6M $1.6M $48.0K
2025-06-30 $7.1M -$280.0K $1.4M $1.6M -$116.0K -0.04
2025-03-31 $6.1M -$625.0K $647.0K $942.0K -$866.0K -0.10
2024-12-31

Insider Transactions
Date Name Role Shares Value
2026-03-26 STACHOWIAK RAYMOND C Officer, Director and Beneficial Owner 100,000
2025-06-26 STACHOWIAK RAYMOND C Officer, Director and Beneficial Owner 110,000
2025-04-30 TAGAWA CRAIG KENJI President 5,613
2024-12-19 FRECH RAYMOND SCOTT Chief Financial Officer 50,000
2024-10-14 DELANOIS GARY Chief Operating Officer 120,000
Top Institutional Holders
Holder Shares Value % Held
Dimensional Fund Advisors LP 205.1K $276.9K 0.0%
Corient Private Wealth LLC 160.6K $216.8K 0.0%
Vanguard Capital Management LLC 153.7K $207.5K 0.0%
Bridgeway Capital Management, LLC 90.8K $122.6K 0.0%
LPL Financial LLC 76.4K $103.1K 0.0%
Renaissance Technologies, LLC 49.2K $66.4K 0.0%
Susquehanna International Group, LLP 42.3K $57.1K 0.0%
DRW Securities, LLC 32.9K $44.4K 0.0%
Geode Capital Management, LLC 32.6K $44.0K 0.0%
NewEdge Advisors, LLC 29.7K $40.1K 0.0%

Analyst Recommendations
2 Months Ago
0 analysts

Last Month
0 analysts

Current
0 analysts

Strong Buy
Buy
Hold
Sell
Strong Sell

Additional Fundamentals
Enterprise Value
$30.8M
Price/Book
0.37
Beta
0.324
Analysts
1
Total Revenue (TTM)
$28.1M
Total Debt
$21.7M
Short Ratio
0.58
Short % Float
0.0%

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite

Trade Consideration

The Opportunity
Score 40.0 (P43 — top 56.8% of scored tickers). Weak Moat. Ethical FAIL. 1 analysts at Strong Buy.
Price: $1.61 | Target: $4.00 (+148%) | Fair Value: $6.00 (+273%)

Score
40

Moat
WEAK

Conviction
Standard

Upside
+148%

The Fundamentals
Revenue Growth-14.8%
Profit Margin-5.5%
ROE-9.4%
Forward P/E4.0
Market Cap$10.7M

Earnings Track Record
Date Estimate Reported Surprise
2026-08-13 $-0.02 Pending
2026-05-14 $-0.01 $-0.09 -800.0%
2026-03-31 $0.02 $-0.09 -550.0%
2025-11-13 $— Pending
2025-08-13 $-0.07 $-0.04 +42.9%
2025-05-15 $0.04 $-0.10 -350.0%
Position Sizing Scenarios
Stop: $1.37 (-15%) | Entry: $1.61
Shares Cost Profit to Target R:R
To Consensus ($4.00, 1 analysts)
10 $16.10 +$23.90 (148%) 10.0R
50 $80.50 +$119.50 (148%) 10.0R
100 $161.00 +$239.00 (148%) 10.0R
To Fair Value ($6.00)
10 $16.10 +$43.90 (273%) 18.3R
50 $80.50 +$219.50 (273%) 18.3R
100 $161.00 +$439.00 (273%) 18.3R
Risk Factors
  • No elevated risk flags in current data

The Verdict
American Shared Hospital Services holds a weak competitive moat and trades at a 272.7% discount to fair value.

Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

D
Quant Score
25.2
Risk Grade
LOW_RISK
Layers
8
Quality: HMM_CRISIS

Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-4.9%
worst expected daily loss, 19 in 20 days
CVaR 95%
-7.9%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
-1.17
above 1.0 is good
Max Drawdown
-64.2%
Worst Day

Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
55
Liquidity Grade
MODERATE

Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal

Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
BELOW_200
Bollinger Position
LOWER_HALF
Beta
Relative Volume
5.1x
Short Interest

Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone

Piotroski F-Score

Earnings Beat Rate
25.0%
Earnings Consistency

Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
Ticker Correlation
PHR 0.209
5332.T 0.205
ICMB 0.191
ITRMF 0.187
BKG.L 0.176
Inverse Correlated
Ticker Correlation
APLS -0.234
KAMCO.KW -0.167
CABLE.KW -0.160
XZO -0.159
Q -0.144

Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Thursday
Worst Day
Monday
Best Month
Sep
Worst Month
Mar
Fri-Mon Effect
0.4758834097987935

Earnings Drift

After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.

Avg Drift After Beat
-4.6%
Beat Drift Positive %
0.0%
Consistency

Momentum Rankings

How does this ticker’s recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
+1.5%
3M Return
-37.8%
6M Return
-34.8%
12M Return
-42.5%
Momentum Rank
#4244
Momentum Signal
STRONG_DOWN

Related Tickers

Similar in Healthcare

INCY — Incyte CRMD — CorMedix Inc. ✓ UHS — Universal Health Services ✓ FENC — Fennec Pharmaceuticals Inc. ✓ REGN — Regeneron Pharmaceuticals ✓

Also in TE500

NEM — Newmont ✓ NU — Nu Holdings Ltd. PTC — PTC Inc. ✓ SBNY — Signature Bank EXE — Expand Energy ✓
Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.